Chronic Epstein-Barr viral load carriage after pediatric organ transplantation

Area of Science:

• Virology
• Immunology
• Transplant Medicine

Background:

• Epstein-Barr virus (EBV) infection is a significant risk factor for post-transplant lymphoproliferative disorder (PTLD) in pediatric solid organ transplant (SOT) recipients.
• Serial EBV monitoring in SOT patients has revealed a subset with chronic high EBV load (CHL), more prevalent in pediatric recipients.
• The biological underpinnings and optimal clinical management of CHL remain poorly understood.

Purpose of the Study:

• To review current knowledge regarding chronic high EBV load (CHL) in pediatric SOT recipients.
• To discuss the potential progression of CHL to EBV-associated PTLD (EBV/PTLD).
• To present expert-adopted clinical approaches for managing CHL.

Main Methods:

• Literature review of EBV monitoring and CHL in SOT recipients.
• Synthesis of current evidence on EBV biology and CHL.
• Compilation of expert-recommended clinical management strategies.

Main Results:

• Chronic high EBV load (CHL) is observed in a subset of pediatric SOT recipients.
• CHL is more common in pediatric versus adult transplant recipients.
• While some CHL cases may progress to EBV/PTLD, the exact risk and underlying mechanisms require further investigation.

Conclusions:

• Understanding the biology of CHL is crucial for preventing EBV/PTLD in pediatric SOT recipients.
• Standardized clinical approaches for CHL management are needed.
• Further research is warranted to elucidate CHL pathogenesis and optimize therapeutic strategies.